Early prediction of acute antidepressant treatment response and remission in pediatric major depressive disorder.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of the American Academy of Child and Adolescent Psychiatry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1097/CHI.0b013e318190043ePMID 19057412PMCID PMC2822388
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Electroencephalographic Alpha Measures Predict Therapeutic Response to a Selective Serotonin Reuptake Inhibitor Antidepressant: Pre- and Post-Treatment Findings

  2009cited by this paper
• Clinical Response and Risk for Reported Suicidal Ideation and Suicide Attempts in Pediatric Antidepressant Treatment: A Meta-analysis of Randomized Controlled Trials

  2009cited by this paper
• Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents.

  2008cited by this paper
• Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findings.

  2008cited by this paper
• Predicting 6‐week treatment response to escitalopram pharmacotherapy in late‐life major depressive disorder

  2007cited by this paper
• Practice parameter for the assessment and treatment of children and adolescents with depressive disorders.

  2007cited by this paper
• Do Children and Adolescents Have Differential Response Rates in Placebo-Controlled Trials of Fluoxetine?

  2007cited by this paper
• Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.

  2007cited by this paper
• Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder.

  2007cited by this paper
• Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder.

  2007cited by this paper
• Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder

  2006cited by this paper
• The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder.

  2006cited by this paper
• Does the Clinical Course of Depression Determine Improvement in Symptoms and Quality of Life?

  2006cited by this paper
• Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS).

  2006cited by this paper
• Review of the efficacy and safety of antidepressants in youth depression.

  2005cited by this paper
• Adolescents With Depression—Reply

  2004cited by this paper
• Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.

  2004cited by this paper
• Tolerability and adherence issues in antidepressant therapy.

  2003cited by this paper
• Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder.

  2000cited by this paper
• on Medication Treatment of Childhood Major Depressive Disorder

  1999cited by this paper
• Prediction of response to fluoxetine and placebo in children and adolescents with major depression: a hypothesis generating study.

  1999cited by this paper
• Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine.

  1999cited by this paper
• Practice Parameters for the Assessment and Treatment of Children and Adolescents With Depressive Disorders

  1998cited by this paper
• Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

  1998cited by this paper
• Limbic-cortical dysregulation: a proposed model of depression.

  1997cited by this paper
• Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data.

  1997cited by this paper
• Small sample inference for fixed effects from restricted maximum likelihood.

  1997cited by this paper
• Controlling the false discovery rate: a practical and powerful approach to multiple testing

  1995influential reference
• The development of clinical paractice guidelines for the diagnosis and treatment of depression

  1992cited by this paper
• The development of clinical practice guidelines for the diagnosis and treatment of depression.

  1992cited by this paper
• The family history approach to diagnosis. How useful is it?

  1986cited by this paper
• A children's global assessment scale (CGAS).

  1983cited by this paper

• Deep transcranial magnetic stimulation for adolescents with treatment-resistant depression: A preliminary dose-finding study exploring safety and clinical effectiveness.

  2024cites this paper
• Deep transcranial magnetic stimulation for adolescents with treatment-resistant depression: Behavioral and neural correlates of clinical improvement.

  2024cites this paper
• Special Populations: Treatment-Resistant Depression in Children and Adolescents.

  2023cites this paper
• Predictors of response to pharmacotherapy in children and adolescents with psychiatric disorders: A combined post hoc analysis of four clinical trial data

  2022cites this paper
• Evidence for machine learning guided early prediction of acute outcomes in the treatment of depressed children and adolescents with antidepressants

  2022cites this paper
• A Characterization of the Clinical Global Impression Scale Thresholds in the Treatment of Adolescent Depression Across Multiple Rating Scales

  2022cites this paper
• Forks in the road: Definitions of response, remission, recovery, and other dichotomized outcomes in randomized controlled trials for adolescent depression. A scoping review

  2021cites this paper
• Predictors of Treatment Outcome in Adolescent Depression

  2021cites this paper
• Detecting Critical Decision Points during Cognitive-Behavioral Therapy and Light Therapy for Winter Depression Nonremission and Recurrence.

  2020cites this paper
• Two Trajectories of Depressive Symptom Reduction Throughout Behavioral Activation Teletherapy Among Underserved, Ethnically Diverse, Primary Care Patients: A VitalSign6 Report.

  2020cites this paper
• Neural and Behavioral Correlates of Clinical Improvement to Ketamine in Adolescents With Treatment Resistant Depression

  2020cites this paper
• Critical Decision Points for Augmenting Interpersonal Psychotherapy for Depressed Adolescents: A Pilot Sequential Multiple Assignment Randomized Trial.

  2019cites this paper
• The Association Between Parental Depression and Child Psychosocial Intervention Outcomes: Directions for Future Research.

  2019cites this paper
• Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study

  2018cites this paper
• Treating a broader range of depressed adolescents with combined therapy.

  2018cites this paper
• Internalizing disorders : The focus on mood and anxiety disorders

  2018cites this paper
• Neural and neuroendocrine predictors of pharmacological treatment response in adolescents with depression: A preliminary study

  2018cites this paper
• Why do depression and anxiety symptoms co-occur across development? : the role of genes, environments and cognition

  2016cites this paper
• Primary Pediatric Care Psychopharmacology: Focus on Medications for ADHD, Depression, and Anxiety.

  2016cites this paper
• AKT question relating to dermatology problems

  2016cites this paper
• Evaluation of a spirituality informed e-mental health tool as an intervention for major depressive disorder in adolescents and young adults – a randomized controlled pilot trial

  2015cites this paper
• Comparison of the effectiveness of duloxetine in depressed patients with and without a family history of affective disorders in first-degree relatives

  2015cites this paper
• Comorbidity of anxiety and depression in children and adolescents: 20 years after.

  2014cites this paper
• Chronotherapeutics: an alternative treatment of juvenile depression.

  2014cites this paper
• Mechanisms of antidepressant resistance

  2013cites this paper
• Brain Imaging and the Prediction of Treatment Outcomes in Mood and Anxiety Disorders

  2013cites this paper
• Depressed Adolescents Treated with Exercise (DATE): A pilot randomized controlled trial to test feasibility and establish preliminary effect sizes.

  2013cites this paper
• Do sub-syndromal manic symptoms influence outcome in treatment resistant depression in adolescents? A latent class analysis from the TORDIA study.

  2012cites this paper
• Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression.

  2012cites this paper
• Insomnia Moderates Outcome of Serotonin-Selective Reuptake Inhibitor Treatment in Depressed Youth

  2012cites this paper
• Child and adolescent depression intervention overview: what works, for whom and how well?

  2012cites this paper
• Predictors of treatment response in adolescent depression.

  2011cites this paper
• Riesgo de suicidio en población pediátrica tratada con antidepresivos: impacto de la alerta de 2003 en la prescripción e investigación en eficacia y seguridad

  2011cites this paper
• Antidepressant Treatment of Pediatric Depression

  2011cites this paper
• Long-Term Outcome of Adolescent Depression Initially Resistant to SSRI Treatment

  2011cites this paper
• Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample.

  2011cites this paper
• Psychopharmacology of depression in children and adolescents.

  2011cites this paper
• Deconstructing pediatric depression trials: an analysis of the effects of expectancy and therapeutic contact.

  2011cites this paper
• Early patterns of symptom change signal remission with interpersonal psychotherapy for depressed adolescents

  2011cites this paper
• Pharmacotherapy for Pediatric major depression

  2010cites this paper
• Pharmacological treatment of depression and bipolar disorder in children and adolescents

  2010cites this paper
• Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes.

  2010cites this paper
• A Systematic Overview of Measurement-Based Care in the Treatment of Childhood and Adolescent Depression

  2010cites this paper
• A Comparison of Various Methods of Measuring Antidepressant Medication Adherence Among Children and Adolescents with Major Depressive Disorder in a 12-Week Open Trial of Fluoxetine

  2010cites this paper
• Anxiety As a Predictor of Treatment Outcome in Children and Adolescents with Depression

  2010influential citation
• Pharmacotherapy and psychotherapy of pediatric depression

  2010cites this paper
• Symptom Improvement and Residual Symptoms during Acute Antidepressant Treatment in Pediatric Major Depressive Disorder

  2010influential citation
• Psychometric Properties of the Children's Depression Rating Scale–Revised in Adolescents

  2010cites this paper
• Predicting Remission in Depressed Children Treated with Fluoxetine

  2009cites this paper
• Early response to antidepressant treatment in bulimia nervosa

  2009influential citation
• Effectiveness and tolerability of citalopram for the treatment of depression and anxiety disorders in children and adolescents: an open-label study

  2009cites this paper